Mesangiolytic glomerulopathy in severe congestive heart failure

Kidney International

Volumn 53, Issue 4, 1998, Pages 880-891

  Yoshida, Haruyoshi ^a   Yashiro, Masatomo ^b   Liang, Ping ^b   Muso, Eri ^b   Takeuchi, Eiji ^b   Shimada, Toshihide ^b   Sekita, Ken Ichi ^b   Ono, Takahiko ^b   Kanatsu, Kazuro ^b   Sugiyama, Taketoshi ^b   Kawai, Chuichi ^b   Sasayama, Shigetake ^b  

^a Kitano Hospital   (Japan)

^b NONE

Author keywords

Angiotensin II; Congestive heart failure; Glomerulomegaly; Hypoxia; Macrophage; Mesangiolysis

Indexed keywords

CAPTOPRIL; DIGITALIS; DIURETIC AGENT; NIFEDIPINE;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULOPATHY; HUMAN; MALE; MESANGIUM; MICROANEURYSM; PRIORITY JOURNAL; UREMIA;

EID: 14444275316     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00830.x     Document Type: Article

References (43)

1. PASTAN SO, BRAUNWALD E: Renal disorders and heart disease, in Heart Disease (4th ed), edited by BRAUNWALD E, Philadelphia, WB Saunders Company, 1992, pp 1856-1874
2. DZAU VJ: Renal and circulatory mechanisms in congestive heart failure. Kidney Int 31:1402-1415, 1987
3. KASTNER PR, HALL JE, GUYTON AC: Control of glomerular filtration rate; Role of intrarenally formed angiotensin II. Am J Physiol 246: F897-F906, 1984
4. ICHIKAWA I, PFEFFER JM, PFEFFER MA, HOSTETTER TH, BRENNER BM: Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 55:669-675, 1984
5. ICHIKAWA I, HARRIS RC: Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int 40:583-596, 1991
6. MATSUSAKA T, HYMES J, ICHIKAWA I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 7:2025-2043, 1996
7. HILTON PJ, JONES NF, TIGHE JR: Nephrotic syndrome with heart disease: A reappraisal. Brit Med J 3:584-586, 1968
8. RACE GA, SCHEIFLEY CH, EDWARDS JE: Albuminuria in congestive heart failure. Circulation 13:329-333, 1956
9. BURACK WR, PRYCE J, GOODWIN JF: A reversal nephrotic syndrome associated with congestive heart failure. Circulation 18:562-571, 1958
10. PAUL O, VAWTER GF, SCHWEITZER AW, HASS GM: Pathological changes in congestive heart failure. AMA Arch Pathol 64:363-380, 1957
11. LEWIS RM, VERANI RR, VO C, KATZ SM, BUREN CTV, RADOVANCEVIC B, KERMAN RH, FRAZIER OH, KAHAN BD: Evaluation of chronic renal disease in heart transplant recipients: Importance of pretransplantation native kidney histologic evaluation. J Heart lung Transplant 13:376-380, 1994
12. SPEAR GS: The glomerular alterations in cyanotic congenital heart disease. Bull Johns Hopkins Hosp 106:347-359, 1960
13. INGELFINGER JR, KISSANE JM, ROBSON AM: Glomerulomegaly in a patients with cyanotic congenital heart disease. Am J Dis Child 120:69-71, 1970
14. BAUER WC, ROSENBERG BF: A quantitative study of glomerular enlargement in children with tetralogy of Fallot. Am J Pathol 37:695-712, 1960
15. BURKE JR, GLASGOW EF, MCCREDIE DA, POWELL HR: Nephropathy in cyanotic congenital heart disease. Clin Nephrol 7:38-42, 1977
16. SORBINI CA, GRASSI V, SOLINAS E, MUIESAN G: Arterial oxygen tension in relation to age in healthy subjects. Respiration 25:3-13, 1968
17. MORITA T, CHURG J: Mesangiolysis. Kidney Int 24:1-9, 1983
18. ONO T, MUSO E, SUYAMA K, OYAMA A, MATSUSHIMA H, YASHIRO M, KUWAHARA T, YOSHIDA H, KANATSU K, SASAYAMA S: Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schönlein purpura nephritis. Nephron 74:522-528, 1996
19. MORITA T, KIHARA I, OITE T, YAMAMOTO T, SUZUKI Y: Mesangiolysis; sequential ultrastructural study of Habu venom-induced glomerular lesions. Lab Invest 38:94-102, 1978
20. SHIGEMATSU H, DIKMAN SH, CHURG J, GRISHMAN E, DUFFY JL: Mesangial involvement in hemolytic-uremic syndrome. A light and electron microscopic study. Am J Pathol 85:349-362, 1976
21. BLOODWORTH JMB JR: A re-evaluation of diabetic glomerulosclerosis. 50 years after the discovery of insulin. Human Pathol 9:439-453, 1978
22. SAITO Y, KIDA H, TAKEDA S, YOSHIMURA M, YOKOYAMA H, KOSHINO Y, HATTORI N: Mesangiolysis in diabetic glomeruli: Its role in the formation of nodular lesions. Kidney Int 34:389-396, 1988
23. KODA Y, MARUYAMA Y, OGINO S, HAYASHI H, NISHI S, SAITO T, UENO H, ARAKAWA M: Early mesangiolysis and monocyte influx observed in diabetic glomerulosclerosis: Relation to nodule formation. Jpn J Nephrol 33:33-42, 1991
24. NAKAMOTO Y, IMAI H, YASUDA T, ASAKURA K, MIURA AB, NISHIMURA S: Mesangiolytic glomerulonephritis associated with Takatsuki's syndrome: An analysis of five renal biopsy specimens. Human Pathol 20:243-251, 1989
25. JOH K, USUI N, AIZAWA S, YAMAGUCHI Y, CHIBA S, TAKAHASHI T, MURAMATSU Y, SAKAI S: Focal segmental glomerulosclerosis associated with infantile spasms in five mentally retarded children: A morphological analysis on mesangiolysis. Am J Kidney Dis 5:569-577, 1991
26. WALKER JD, BURKE B, STEFFES MW, MAUER M: Glomerular volume in congestive cardiac failure. Nephron 76:143-145, 1997
27. HAGLEY MT, MURPHY DP, MULLINS D, ZARCONI J: Decline in creatinine clearance in a patient with glomerulomegaly associated with a congenital cyanotic heart disease. Am J Kidney Dis 20:177-179, 1992
28. KIM SB, KANG SA, PARK JS, LEE JS, HONG CD: Effects of hypoxia on the extracellular matrix production of cultured rat mesangial cells. Nephron 72:275-280, 1996
29. KOUREMBANAS S, MARSDEN PA, MCQUILLAN LP, FALLER DV: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88:1054-1057, 1991
30. KRAMER BK, BUCHER M, SANDNER P, ITTNER KP, RIEGGER GAJ, RITTHALER T, KURTZ A: Effects of hypoxia on growth factor expression in the rat kidney in vivo. Kidney Int 51:444-447, 1997
31. KAGAMI S, BORDER WA, MILLER DE, NOBLE DE: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
32. GOETZL EJ, KLICKSTEN LB, WATT KWK, SINTROUB BU: The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II. Biochem Biophys Res Commun 97:1097-1102, 1980
33. WEINSTOCK JV, KASSAB JT: Angiotensin II stimulation of granuloma macrophage phagocytosis and actin polymerization in murine schistosomiasis mansoni. Cell Immunol 89:46-54, 1984
34. CATTELL V: Macrophages in acute glomerular inflammation. Kidney Int 45:945-952, 1994
35. NIKOLIC-PATERSON DJ, LAN HY, HILL PA, ATKINS RC: Macrophages in renal injury. Kidney Int 45(Suppl):S79-S82, 1994
36. HELMCHEN U, WENZEL UO: Benign and malignant nephrosclerosis and renovascular disease, in Renal Pathology (vol 2; 2nd ed), edited by TISHER CC, BRENNER BM, Philadelphia, JB Lippincott Company, 1994, pp 1201-1238
37. COHN JN: Current therapy of the failing heart. Circulation 78:1099-1107, 1988
38. ANDERSON J, DIAMOND JR, KARNOVSKY MJ, BRENNER BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82:1757-1768, 1988
39. YOSHIDA Y, KAWAMURA T, IKOMA M, FOGO A, ICHIKAWA I: Effects of antihypertensive drugs on glomerular morphology. Kidney Int 36:626-635, 1989
40. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
41. OMATA K, KANAZAWA M, SATO T, ABE F, SAITO T, ABE K: Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease. Kidney Int 49(Suppl):S57-S62, 1996
42. THE CONSENSUS TRIAL STUDY GROUP: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316:1429-1435, 1987
43. YOSHIDA H, MATSUSHIMA H, MACHIGUCHI T, TAMURA T, MUSO E, SASAYAMA S: Glomerular hyperfiltration and sclerosis in chronic congestive heart failure, (abstract) J Am Soc Nephrol 6:689, 1995